NCT05193981View on ClinicalTrials.gov

A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 14, 2021

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Autosomal Dominant Polycystic Kidney Disease
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT05193981 - A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD | Biotech Hunter | Biotech Hunter